Short- and Long-Term Mortality for Patients With and Without a Cancer Diagnosis Following Pulmonary Embolism in Denmark, 2000 to 2020: A Nationwide Study.
Sophie Fredslund MadsenDaniel Mølager ChristensenJarl Emanuel StrangeNina NouhraveshThomas KümlerGunnar Hilmar GislasonMorten LambertsCaroline Sindet-PedersenPublished in: Journal of the American Heart Association (2023)
From 2000 to 2020, improvements were observed in 30-day mortality following pulmonary embolism regardless of cancer status. For patients with recent cancer, 31- to 365-day mortality did not improve, whereas a minor improvement was observed for patients without recent cancer.
Keyphrases
- pulmonary embolism
- papillary thyroid
- squamous cell
- inferior vena cava
- end stage renal disease
- cardiovascular events
- chronic kidney disease
- squamous cell carcinoma
- ejection fraction
- lymph node metastasis
- newly diagnosed
- cardiovascular disease
- type diabetes
- prognostic factors
- coronary artery disease
- peritoneal dialysis
- patient reported